LIGENT (09856.HK): Lists at HKD 32.96 per Share, HK Public Offer 35.16 Times Subscribed
- The Hong Kong public offering received 37,594 valid applications and 13,561 successful applications; the international offering had 192 placees.
- Gross proceeds were HKD 5,669.6 million, with estimated listing expenses of HKD 224.3 million and net proceeds of HKD 5,445.3 million; 25,802,200 offer shares were over-allocated.
- The number of shares in issue after listing (before exercise of the over-allotment option) is 982,941,500, in board lots of 100 shares.
NewTimeSpace News: On 21 September 2026, Ligent Technologies, Inc. (stock code: 09856) published its allotment results announcement. The number of offer shares under the global offering is 172,014,700 shares (subject to the exercise of the over-allotment option) at an offer price of HKD 32.96 per share.
Of these, the final number of offer shares under the Hong Kong public offering is 17,201,500 shares, representing 10% of the offer shares under the global offering, with a subscription level of 35.16 times, 37,594 valid applications and 13,561 successful applications; the final number of offer shares under the international offering is 154,813,200 shares, representing 90%, with a subscription level of 4.67 times and 192 placees.
Gross proceeds from the global offering amounted to HKD 5,669.6 million, and after deducting estimated listing expenses payable of HKD 224.3 million calculated at the offer price, net proceeds were HKD 5,445.3 million. The number of offer shares subject to over-allocation is 25,802,200 shares, which may be covered by exercising the over-allotment option, by purchasing shares in the secondary market at a price not exceeding the offer price, by deferred delivery, or by a combination of these.
The announcement also set out that cornerstone investors were allocated an aggregate of 80,876,700 offer shares, representing approximately 47.02% of the total offer shares and approximately 8.23% of the Company's total issued share capital following the global offering. For the global offering, CLSA Limited acts as the stabilising manager, and the stabilising period is expected to expire on 17 October 2026.
Assuming the global offering becomes unconditional at or before 8:00 a.m. on 22 September 2026, the shares are expected to commence trading on the Stock Exchange at 9:00 a.m. on 22 September 2026, in board lots of 100 shares, under stock code 9856. The number of shares in issue after listing (before exercise of the over-allotment option) is 982,941,500.
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
- LEADS BIOLABS-B (09887.HK): Pivotal EP-NEC Study Selected as ESMO Late-Breaking Abstract
- GREEN BROAD (01253.HK): To Issue 595.09 Million Swap Shares to Settle Debt, Cut Offshore Debt by About 52%
- SCHOLAR EDU (01769.HK): Trustee Buys 135,000 Shares Under Share Award Scheme at HKD 0.84 Average
- UNITY ENT (02195.HK): Interim Revenue HKD 114.1 Million, Loss Narrows to HKD 13.0 Million
- GUOFUHEE (02582.HK): Interim Loss Widens to RMB 122.5 Million, Revenue Down 4.5%